Comparing palliative care quality between designated and non-designated cancer hospitals: A secondary analysis of bereaved family surveys

This secondary analysis of bereaved family surveys reveals that while patients in non-designated cancer hospitals were older and less symptomatic than those in designated hospitals, the overall quality of palliative care and family satisfaction were comparable between the two settings.

The Gist

Imagine the healthcare system in Japan as a vast network of restaurants. Some are "Michelin-starred" Designated Cancer Hospitals, equipped with specialized chefs (palliative care teams) and top-tier ingredients, specifically trained to handle the most complex culinary challenges. Others are Non-Designated Hospitals, which are more like local neighborhood diners or community cafes. They serve the vast majority of people, but they aren't officially labeled as the "specialists."

For a long time, people assumed that if you wanted the best "meal" (palliative care) at the end of life, you had to go to the Michelin-starred restaurant. The assumption was that the neighborhood diners were just doing the bare minimum.

This study decided to put that assumption to the test by asking the most important critics: the bereaved families. They surveyed nearly 28,000 families whose loved ones passed away in 2018. They asked these families to rate the "meal" their loved ones received, looking at how well symptoms were managed, how satisfied they were, and whether important end-of-life conversations happened.

Here is what they found, broken down simply:

1. The "Customers" Were Different

Before comparing the food, the researchers noticed the customers were very different.

• The Michelin-Starred Hospitals: These places were caring for patients who were generally younger (average age 73) and, surprisingly, were in more pain and distress. It's like a high-end kitchen getting the most difficult, complex orders.
• The Neighborhood Diners: These hospitals were caring for patients who were significantly older (average age 80) and were often frailer, with more memory issues and difficulty moving around. However, these patients were actually experiencing less intense physical pain than those in the specialized hospitals.

2. The "Food Quality" Was Surprisingly Similar

Despite the difference in the customers and the complexity of the orders, the families' ratings of the care were remarkably similar.

• Symptom Management: Even though the specialized hospitals had patients with more severe symptoms, the families didn't rate the symptom relief significantly better there than in the community hospitals.
• Overall Satisfaction: Here is the twist: Families actually felt slightly more satisfied with the care in the non-designated (community) hospitals.
• The "Good Death" Score: When families were asked if their loved one's final days felt peaceful and aligned with their wishes, the scores were almost identical between the two types of hospitals.

3. The "Menu Planning" (End-of-Life Discussions)

The study also checked if families and doctors had talked about what the patient wanted (like where they wanted to die or if they wanted CPR).

• The Result: It didn't matter which type of hospital the patient was in. The rate of these important conversations was basically the same. The "Michelin-starred" chefs weren't having more planning meetings than the "neighborhood" staff.

The Big Takeaway

The study concludes that while Designated Cancer Hospitals are indeed handling the "heavier lifting" with sicker, more symptomatic patients, the Non-Designated Hospitals are doing just as good a job at the core task of palliative care.

Think of it like this: If a neighborhood diner can serve a warm, comforting meal to an elderly, tired traveler just as well as a fancy restaurant can serve a complex dish to a younger guest, then the "specialist" label isn't the only thing that matters. The study suggests that basic training and standard care practices (like the national "PEACE" program mentioned in the paper) have helped level the playing field, so that the quality of care feels the same to the families, regardless of the hospital's official badge.

In short: The specialized hospitals get the harder cases, but the community hospitals are providing care that feels just as good to the families who are left behind.

Technical Summary

Technical Summary: Comparing Palliative Care Quality Between Designated and Non-Designated Cancer Hospitals

Problem Statement
In Japan, approximately 70% of cancer deaths occur in non-designated community hospitals, yet the quality of palliative care provided in these facilities remains largely unevaluated. While designated cancer hospitals (operating under the Cancer Control Act) are mandated to have specialized Palliative Care Consultation Teams and have demonstrated significant development in palliative services between 2008 and 2018, the care delivered in non-designated settings is often presumed to be insufficient. There is a critical need to empirically compare the quality of palliative care between these two hospital types to determine if the designation status correlates with actual care outcomes as perceived by stakeholders.

Methodology
This study conducted a secondary analysis of a nationwide survey involving bereaved family members of patients with cancer who died in 2018. The study excluded deaths occurring in palliative care units to focus on general hospital settings.

• Data Source: Stratified random sampling based on the 2018 Vital Statistics Survey of Death Lists.
• Participants: 27,944 bereaved family members agreed to participate, with 13,995 valid responses included in the final analysis (4,821 from designated hospitals and 9,174 from non-designated hospitals).
• Survey Instrument: A mailed questionnaire was sent 13–25 months post-bereavement.
• Measurement Tools:
  • Care Evaluation Scale (CES): Assessed medical care structure and process (13 items).
  • Good Death Inventory (GDI): Quantified the achievement of a desired death (18 items).
  • Memorial Symptom Assessment Scale (MSAS): Measured physical symptom intensity (11 items used).
  • Satisfaction: A single-item measure of overall satisfaction.
  • End-of-Life Discussions: Assessed the implementation of discussions regarding care location and medical preferences.
• Statistical Analysis: The study compared patient and family characteristics, care quality scores, and discussion rates between the two groups using Student's t-tests and chi-square tests. Crucially, multiple regression analyses were performed to adjust for confounding patient characteristics (e.g., age, ADL status, dementia) to isolate the effect of hospital designation on care quality. Effect sizes (Cohen's d and Cramer's V) were calculated to assess clinical significance.

Key Results

• Patient Demographics: Significant differences were observed in patient populations. Patients in non-designated hospitals were significantly older (mean age 79.7 vs. 73.2 years; ES = 0.55) and exhibited greater functional impairment, including lower Activities of Daily Living (ADL) scores, reduced communication ability, and a higher prevalence of dementia compared to those in designated hospitals.
• Symptom Burden: After adjusting for patient characteristics, the MSAS total scores (symptom intensity) were significantly higher in designated hospitals (ES = 0.39), indicating that patients in these facilities experienced more intense symptom burdens.
• Care Quality and Satisfaction:
  • Satisfaction: Contrary to the assumption that designated hospitals provide superior care, the adjusted mean overall satisfaction was significantly higher in non-designated hospitals (ES = 0.21), though the effect size was small.
  • CES and GDI: No clinically meaningful differences were found in the Care Evaluation Scale or Good Death Inventory scores between the two groups after adjustment.
• End-of-Life Discussions: The rates of end-of-life discussions regarding care location and resuscitation preferences were similar across both hospital types. While some statistical differences existed, the effect sizes were negligible (ES < 0.2), suggesting comparable implementation of these discussions regardless of hospital designation.

Significance and Claims
The primary contribution of this study is the finding that, from the perspective of bereaved families, there is no clinically significant difference in the perceived quality of palliative care between designated and non-designated cancer hospitals. This challenges the prevailing assumption that non-designated hospitals provide inadequate palliative services compared to their designated counterparts.

The authors suggest that this parity may be attributed to the standardization of generalist palliative care, potentially driven by national initiatives such as the PEACE program (Palliative care Emphasis program on symptom management and Assessment for Continuous medical Education), which has trained over 100,000 physicians. The study concludes that hospital designation status alone is not a sufficient indicator of palliative care quality; rather, the quality of care appears to be relatively comparable across institutions, even when serving older, frailer, and less symptomatic patient populations in non-designated settings.

Limitations
The authors acknowledge several limitations:

1. Proxy Evaluation: Data relies on bereaved family members rather than direct patient evaluation, though this is standard for terminal care research.
2. Transfer Status: The study could not account for patient transfers in the final month of life, potentially obscuring the actual place of care versus the place of death.
3. Non-Response Bias: With a 54% response rate, there is a possibility that non-respondents held more negative views, potentially leading to an overestimation of care quality.
4. Treatment History: The classification was based solely on the place of death, not necessarily where the majority of treatment occurred.
5. Specialist Involvement: The study could not assess the specific involvement of specialist palliative care teams in the end-of-life phase.